Nifty
Sensex
:
:
22795.90
75311.06
-117.25 (-0.51%)
-424.90 (-0.56%)

Pharmaceuticals & Drugs - API

Rating :
N/A

BSE: 524558 | NSE: NEULANDLAB

14484.45
06-Feb-2025
  • Open
  • High
  • Low
  • Previous Close
  •  15020.00
  •  15220.00
  •  14357.65
  •  14817.50
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  20554
  •  3036.26
  •  18100.00
  •  5540.10

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 14,109.22
  • 47.05
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 14,116.37
  • 0.13%
  • 9.43

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 32.68%
  • 5.34%
  • 26.04%
  • FII
  • DII
  • Others
  • 23.86%
  • 7.26%
  • 4.82%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.76
  • 15.36
  • 17.90

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 21.38
  • 35.34
  • 26.53

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 34.11
  • 79.26
  • 67.53

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 32.46
  • 28.26
  • 26.15

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.85
  • 4.27
  • 5.62

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 16.28
  • 16.78
  • 19.02

Earnings Forecasts:

Description
2024
2025
2026
2027
Adj EPS
233.89
250.46
385.6
490.56
P/E Ratio
68.7
64.16
41.67
32.76
Revenue
1516
1641
2163
2686
EBITDA
463
467
711
896
Net Income
300
308
497
633
ROA
17.6
P/Bk Ratio
16.07
12.96
9.92
7.63
ROE
26.36
21.39
26.96
26.33
FCFF
112.02
287.93
358.15
435.04
FCFF Yield
0.59
1.5
1.87
2.27

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Net Sales
398.03
392.83
1.32%
310.84
417.75
-25.59%
439.60
362.99
21.11%
385.01
407.07
-5.42%
Expenses
311.43
271.56
14.68%
248.62
280.26
-11.29%
316.24
266.07
18.86%
278.09
287.21
-3.18%
EBITDA
86.60
121.27
-28.59%
62.23
137.49
-54.74%
123.36
96.92
27.28%
106.92
119.86
-10.80%
EBIDTM
21.76%
30.87%
20.02%
32.91%
28.06%
26.70%
27.77%
29.44%
Other Income
3.91
2.10
86.19%
4.33
3.05
41.97%
4.81
2.04
135.78%
5.36
8.06
-33.50%
Interest
2.22
3.74
-40.64%
1.06
4.43
-76.07%
2.67
2.21
20.81%
3.61
4.29
-15.85%
Depreciation
16.30
15.14
7.66%
16.07
14.51
10.75%
16.28
13.59
19.79%
16.46
13.47
22.20%
PBT
127.77
104.48
22.29%
49.42
121.59
-59.36%
129.84
83.16
56.13%
92.20
110.16
-16.30%
Tax
26.18
23.09
13.38%
16.58
32.35
-48.75%
31.97
21.28
50.23%
24.64
25.62
-3.83%
PAT
101.59
81.39
24.82%
32.84
89.25
-63.20%
97.87
61.88
58.16%
67.56
84.54
-20.09%
PATM
25.52%
20.72%
10.57%
21.36%
22.26%
17.05%
17.55%
20.77%
EPS
78.75
63.09
24.82%
25.46
69.18
-63.20%
75.86
47.96
58.17%
52.37
65.53
-20.08%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
1,533.48
1,558.58
1,191.20
951.08
936.91
762.71
666.83
527.41
578.89
509.97
469.15
Net Sales Growth
-2.98%
30.84%
25.25%
1.51%
22.84%
14.38%
26.43%
-8.89%
13.51%
8.70%
 
Cost Of Goods Sold
598.24
577.29
478.23
422.14
438.42
380.20
366.24
238.37
262.90
253.46
243.99
Gross Profit
935.24
981.30
712.97
528.94
498.50
382.51
300.59
289.04
315.99
256.52
225.16
GP Margin
60.99%
62.96%
59.85%
55.61%
53.21%
50.15%
45.08%
54.80%
54.59%
50.30%
47.99%
Total Expenditure
1,154.38
1,095.99
919.36
808.46
790.09
660.82
608.46
476.98
472.55
429.52
402.53
Power & Fuel Cost
-
48.72
48.62
42.21
39.21
32.75
26.81
25.95
25.78
22.24
22.53
% Of Sales
-
3.13%
4.08%
4.44%
4.19%
4.29%
4.02%
4.92%
4.45%
4.36%
4.80%
Employee Cost
-
257.06
201.79
182.47
149.74
123.56
110.46
102.99
92.74
65.38
51.81
% Of Sales
-
16.49%
16.94%
19.19%
15.98%
16.20%
16.56%
19.53%
16.02%
12.82%
11.04%
Manufacturing Exp.
-
107.79
86.94
89.16
77.10
64.84
50.10
55.54
44.90
39.31
43.56
% Of Sales
-
6.92%
7.30%
9.37%
8.23%
8.50%
7.51%
10.53%
7.76%
7.71%
9.28%
General & Admin Exp.
-
60.91
51.22
35.80
38.93
27.75
27.49
33.32
28.30
29.72
23.59
% Of Sales
-
3.91%
4.30%
3.76%
4.16%
3.64%
4.12%
6.32%
4.89%
5.83%
5.03%
Selling & Distn. Exp.
-
33.94
29.58
27.40
34.63
18.30
18.28
14.04
11.16
17.52
14.54
% Of Sales
-
2.18%
2.48%
2.88%
3.70%
2.40%
2.74%
2.66%
1.93%
3.44%
3.10%
Miscellaneous Exp.
-
10.29
22.99
9.28
12.08
13.42
9.08
6.77
6.78
1.89
14.54
% Of Sales
-
0.66%
1.93%
0.98%
1.29%
1.76%
1.36%
1.28%
1.17%
0.37%
0.54%
EBITDA
379.11
462.59
271.84
142.62
146.82
101.89
58.37
50.43
106.34
80.45
66.62
EBITDA Margin
24.72%
29.68%
22.82%
15.00%
15.67%
13.36%
8.75%
9.56%
18.37%
15.78%
14.20%
Other Income
18.41
12.54
9.75
2.08
16.10
3.89
3.49
4.53
1.17
1.78
0.78
Interest
9.56
14.00
13.07
13.50
17.90
21.57
15.66
18.93
21.09
24.48
27.36
Depreciation
65.11
59.70
52.78
49.04
39.68
31.28
25.86
22.10
19.23
15.74
15.32
PBT
399.23
401.44
215.75
82.16
105.33
52.92
20.34
13.93
67.19
42.00
24.72
Tax
99.37
101.36
52.23
18.34
24.70
36.71
3.90
1.87
20.32
14.92
8.79
Tax Rate
24.89%
25.25%
24.21%
22.32%
23.45%
69.37%
19.17%
13.42%
30.24%
35.52%
35.56%
PAT
299.86
300.08
163.52
63.82
80.63
16.21
16.44
12.06
46.86
27.33
15.94
PAT before Minority Interest
299.86
300.08
163.52
63.82
80.63
16.21
16.44
12.06
46.86
27.08
15.93
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.25
0.01
PAT Margin
19.55%
19.25%
13.73%
6.71%
8.61%
2.13%
2.47%
2.29%
8.09%
5.36%
3.40%
PAT Growth
-5.42%
83.51%
156.22%
-20.85%
397.41%
-1.40%
36.32%
-74.26%
71.46%
71.46%
 
EPS
234.27
234.44
127.75
49.86
62.99
12.66
12.84
9.42
36.61
21.35
12.45

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
1,282.70
994.10
840.50
786.46
709.96
699.31
558.04
545.62
186.63
161.38
Share Capital
12.90
12.90
12.90
12.90
12.90
12.90
8.95
8.95
8.95
8.95
Total Reserves
1,269.80
981.20
827.60
773.56
697.06
686.41
238.24
225.81
177.68
152.42
Non-Current Liabilities
122.17
146.71
179.83
169.82
163.39
104.06
146.43
54.37
69.42
54.76
Secured Loans
44.92
74.25
104.25
88.13
77.37
60.72
103.49
29.81
33.40
21.22
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
12.00
12.00
Long Term Provisions
7.61
10.29
11.91
9.44
12.49
11.91
9.87
9.28
6.85
6.38
Current Liabilities
427.68
438.96
363.16
368.51
357.63
326.98
366.93
285.60
268.00
295.14
Trade Payables
191.96
171.01
117.38
152.13
115.56
119.68
124.29
85.92
83.86
111.81
Other Current Liabilities
234.01
244.87
152.35
158.75
71.63
57.45
41.83
47.18
55.02
31.28
Short Term Borrowings
0.00
11.16
92.21
56.98
168.17
149.06
199.20
151.08
123.63
145.80
Short Term Provisions
1.72
11.93
1.21
0.64
2.27
0.80
1.59
1.41
5.50
6.25
Total Liabilities
1,832.55
1,579.77
1,383.49
1,324.79
1,230.98
1,130.35
1,071.40
885.59
524.05
511.53
Net Block
804.64
738.19
747.70
696.94
622.76
511.69
445.01
435.74
138.77
123.07
Gross Block
1,072.98
950.36
913.27
826.48
714.33
575.44
483.45
454.74
291.78
263.65
Accumulated Depreciation
268.34
212.17
165.57
129.54
91.57
63.75
38.44
19.00
153.00
140.58
Non Current Assets
911.48
818.87
802.70
775.20
715.79
676.88
624.20
510.54
209.87
195.76
Capital Work in Progress
45.89
40.57
20.46
17.25
23.75
104.47
126.09
19.60
40.48
41.47
Non Current Investment
1.28
0.52
0.50
19.35
30.17
30.21
30.21
30.20
7.39
7.39
Long Term Loans & Adv.
40.47
20.24
14.38
41.67
35.81
30.51
22.66
24.79
22.73
23.83
Other Non Current Assets
0.17
0.00
0.00
0.00
3.30
0.00
0.22
0.22
0.50
0.00
Current Assets
921.08
760.89
580.79
549.59
515.19
453.47
447.19
375.04
314.19
315.77
Current Investments
0.00
0.00
3.38
6.46
7.50
7.50
7.50
7.50
0.00
0.00
Inventories
350.42
279.23
265.21
247.61
219.55
192.65
175.09
135.11
126.66
113.40
Sundry Debtors
373.53
361.77
234.33
217.73
189.89
164.02
193.92
181.11
119.11
128.85
Cash & Bank
116.80
59.10
20.36
19.40
46.98
37.84
17.26
12.49
9.71
6.98
Other Current Assets
80.33
13.70
11.52
8.84
51.27
51.46
53.43
38.83
58.70
66.53
Short Term Loans & Adv.
62.03
47.09
46.00
49.55
33.80
31.77
37.15
25.30
46.68
45.23
Net Current Assets
493.40
321.94
217.64
181.08
157.55
126.49
80.27
89.45
46.18
20.63
Total Assets
1,832.56
1,579.76
1,383.49
1,324.79
1,230.98
1,130.35
1,071.39
885.58
524.06
511.53

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
261.18
237.21
60.39
189.36
57.34
69.91
11.27
38.68
44.83
13.17
PBT
401.44
215.75
82.16
105.33
52.92
20.34
13.93
67.19
42.00
24.72
Adjustment
62.08
77.93
66.30
40.08
58.28
39.11
40.43
43.96
33.73
36.34
Changes in Working Capital
-90.73
-12.83
-67.58
49.22
-49.17
15.47
-40.02
-55.94
-19.17
-38.76
Cash after chg. in Working capital
372.78
280.84
80.88
194.63
62.03
74.91
14.35
55.20
56.56
22.30
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-111.60
-43.63
-20.49
-5.27
-4.68
-5.01
-3.08
-16.52
-11.73
-9.13
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-149.69
-61.50
-95.52
-84.42
-48.68
-77.23
-116.29
-42.11
-19.86
-14.13
Net Fixed Assets
-127.92
-60.11
-90.00
-105.64
-58.17
-70.35
-135.20
-142.08
-27.14
-12.02
Net Investments
-0.76
3.36
21.92
11.87
0.04
0.00
-0.01
-30.31
0.12
-0.03
Others
-21.01
-4.75
-27.44
9.35
9.45
-6.88
18.92
130.28
7.16
-2.08
Cash from Financing Activity
-69.28
-135.80
37.72
-113.66
-5.48
11.98
104.85
-0.09
-23.62
1.15
Net Cash Inflow / Outflow
42.21
39.92
2.59
-8.72
3.18
4.66
-0.17
-3.51
1.35
0.19
Opening Cash & Equivalents
45.42
5.09
2.44
11.20
7.94
3.29
3.44
6.97
0.81
0.62
Closing Cash & Equivalent
87.58
45.42
5.09
2.44
11.20
7.94
3.29
3.44
2.16
0.81

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
999.07
774.12
654.40
612.28
552.65
544.35
277.21
263.23
209.07
180.72
ROA
17.59%
11.04%
4.71%
6.31%
1.37%
1.49%
1.23%
6.65%
5.23%
3.20%
ROE
26.38%
17.84%
7.85%
10.79%
2.30%
3.48%
5.02%
22.34%
15.64%
11.24%
ROCE
33.51%
20.94%
9.44%
12.81%
7.85%
3.99%
4.07%
15.98%
18.57%
15.75%
Fixed Asset Turnover
1.54
1.28
1.09
1.22
1.18
1.26
1.13
1.57
1.86
1.82
Receivable days
86.10
91.33
86.74
79.40
84.68
97.96
129.34
93.22
87.45
94.81
Inventory Days
73.73
83.41
98.40
91.00
98.63
100.64
106.98
81.29
84.66
79.24
Payable days
114.75
110.05
116.52
111.44
65.43
75.72
82.06
67.03
85.01
92.70
Cash Conversion Cycle
45.08
64.68
68.63
58.96
117.88
122.89
154.27
107.48
87.10
81.35
Total Debt/Equity
0.06
0.12
0.28
0.22
0.37
0.33
1.30
0.82
0.98
1.17
Interest Cover
29.68
17.51
7.09
6.89
3.45
2.30
1.74
4.19
2.72
1.90

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.